Eclipsys reveals intent to acquire eSys Medical
Eclipsys Corp. this week announced its intent to acquire eSys Medical Systems Inc., a radiology information system (RIS) company.
Under the terms of the agreement, eSys Medical will operate as a subsidiary of Eclipsys and retain its offices in Montreal, Quebec, and Toronto, Ontario. Financial details related to the transaction were not disclosed.
Eclipsys said a key driver for the acquisition is eSys Medical's RadioLogic product, a full-featured RIS. RadioLogic provides both on- and off-site system access for referring physicians, radiologists and transcribers.
Currently licensed by nearly 100 hospitals and outpatient imaging centers, RadioLogic will be re-branded as Sunrise RIS immediately following the completion of the acquisition, Eclipsys said.
With the addition and integration of Sunrise RIS, Eclipsys said it will extend its clinical workflow systems in radiology to boost productivity, lower costs and enhance patient care. The acquisition also broadens and deepens Eclipsys' diagnostic imaging solution, opens up new PACS and RIS sales opportunities through integration with other clinical order/results systems, Eclipsys said.
According to Dave Glickman, eSys Medical Systems CEO, the acquisition will enable the companies to offer eSys Medical's RIS not only as part of a diagnostic imaging system, but also with Sunrise Clinical Manager as part of an enterprise healthcare information system.
This announcement comes on the heels of Eclipsys' co-development agreement with Sectra AB, a PACS vendor. As such, Eclipsys will now be able to offer an integrated imaging system. As a consequence of this acquisition, Eclipsys said it has created a new product family that will be known as Eclipsys Diagnostic Imaging Solutions, which will include Sunrise RIS and Sunrise PACS. This new product family represents a convergence of technologies to form a unique integrated solution.
Sunrise RIS will be integrated with Sunrise PACS and also with Sunrise Clinical Manager. To maximize sales opportunities, Eclipsys said Sunrise RIS will also be sold by Eclipsys and its distributors as a stand-alone system that can be interfaced with PACS or clinical systems from other vendors.
Under the terms of the agreement, eSys Medical will operate as a subsidiary of Eclipsys and retain its offices in Montreal, Quebec, and Toronto, Ontario. Financial details related to the transaction were not disclosed.
Eclipsys said a key driver for the acquisition is eSys Medical's RadioLogic product, a full-featured RIS. RadioLogic provides both on- and off-site system access for referring physicians, radiologists and transcribers.
Currently licensed by nearly 100 hospitals and outpatient imaging centers, RadioLogic will be re-branded as Sunrise RIS immediately following the completion of the acquisition, Eclipsys said.
With the addition and integration of Sunrise RIS, Eclipsys said it will extend its clinical workflow systems in radiology to boost productivity, lower costs and enhance patient care. The acquisition also broadens and deepens Eclipsys' diagnostic imaging solution, opens up new PACS and RIS sales opportunities through integration with other clinical order/results systems, Eclipsys said.
According to Dave Glickman, eSys Medical Systems CEO, the acquisition will enable the companies to offer eSys Medical's RIS not only as part of a diagnostic imaging system, but also with Sunrise Clinical Manager as part of an enterprise healthcare information system.
This announcement comes on the heels of Eclipsys' co-development agreement with Sectra AB, a PACS vendor. As such, Eclipsys will now be able to offer an integrated imaging system. As a consequence of this acquisition, Eclipsys said it has created a new product family that will be known as Eclipsys Diagnostic Imaging Solutions, which will include Sunrise RIS and Sunrise PACS. This new product family represents a convergence of technologies to form a unique integrated solution.
Sunrise RIS will be integrated with Sunrise PACS and also with Sunrise Clinical Manager. To maximize sales opportunities, Eclipsys said Sunrise RIS will also be sold by Eclipsys and its distributors as a stand-alone system that can be interfaced with PACS or clinical systems from other vendors.